NOVEL COMBINATION THERAPY FOR SCHIZOPHRENIA FOCUSED ON IMPROVED COGNITION: 5-HT-2A/D2 BLOCKADE WITH ADJUNCTIVE BLOCKADE OF PREFRONTAL DA REUPTAKE

摘要

The invention disclosed herein involves combinative therapies for the treatment of one or more medical conditions, procedures, and/or diseases. One aspect of the invention involves a combinative therapy for patients and/or subjects diagnosed with schizophrenia comprising an optimal combination of a drug that blocks 5-HT-2A receptors, a drug that blocks D2 receptors and a drug that blocks dopamine reuptake.